Evidence map›Paper›PMID 18614531›Full record

ArticleThe Journal of biological chemistry2008

Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA).

Robin E Duncan, Eszter Sarkadi-Nagy, Kathy Jaworski, Maryam Ahmadian, Hei Sook Sul

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trial
  2. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  3. PLA2G16-Mediated Tetracosatetraenoic Acid Rewires Fatty Acid Oxidation to Impair CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Recent Progress inInternational journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Current Knowledge on Mammalian Phospholipase AMolecules (Basel, Switzerland) · 2022
    Review
  14. PLAAT1 inhibits type I interferon responseFrontiers in immunology · 2022
    Article
  15. Article
  16. Article
  17. Redox Regulation of Lipid Mobilization in Adipose Tissues.Antioxidants (Basel, Switzerland) · 2021
    Review
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Robin E DuncanDepartment of Nutritional Science and Toxicology, University of California, Berkeley, California 94720.
Eszter Sarkadi-NagyDepartment of Nutritional Science and Toxicology, University of California, Berkeley, California 94720.
Kathy JaworskiDepartment of Nutritional Science and Toxicology, University of California, Berkeley, California 94720.
Maryam AhmadianDepartment of Nutritional Science and Toxicology, University of California, Berkeley, California 94720.
Hei Sook SulDepartment of Nutritional Science and Toxicology, University of California, Berkeley, California 94720. Electronic address: hsul@nature.berkeley.edu.
University of California, Berkeley · US

Funding

Pre-doctoral Training in Molecular and Biochemical NutritionT32DK061918 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI NAPOLI, JOSEPH L · 2002 to 2016
$2.6M
Novel adipocyte-specific enzymes in triacylglycerol metabolismR01DK075682 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI SUL, HEI SOOK · 2006 to 2009
$1.1M
NIDDK NIH HHS DK 075682NIDDK NIH HHS R01 DK075682NIDDK NIH HHS T32 DK061918
6 · The paper itself

Abstract

Phospholipases A(2) (PLA(2)s) catalyze hydrolysis of fatty acids from the sn-2 position of phospholipids. Here we report the identification and characterization of a membrane-associated intracellular calcium-dependent, adipose-specific PLA(2) that we named AdPLA (adipose-specific phospholipase A(2)). We found that AdPLA was highly expressed specifically in white adipose tissue and was induced during preadipocyte differentiation into adipocytes. Clearance of AdPLA by immunoprecipitation significantly decreased PLA activity in white adipose tissue lysates but had no effect on liver lysates, where expression was hardly detectable. In characterizing AdPLA, we employed radiochemical assays with TLC analysis of the enzyme activity of lysates from COS-7 cells overexpressing AdPLA. For kinetic studies, we produced purified recombinant AdPLA for use in a lipoxidase-coupled spectrophotometric assay. AdPLA generated free fatty acid and lysophospholipid from phosphatidylcholine with a preference for hydrolysis at the sn-2 position. Although we found low but detectable lysophospholipase activity, AdPLA showed no significant activity against a variety of other lipid substrates. Calcium was found to activate AdPLA but was not essential for activity. Studies with known phospholipase inhibitors, including bromoenolactone, methyl arachidonyl fluorophosphate, AACOCF(3), 7,7-dimethyl-5,8-eicosadienoic acid, and thioetheramide, supported that AdPLA is a phospholipase. Mutational studies showed that His-23 and Cys-113 are critical for activity of AdPLA and suggested that AdPLA is likely a His/Cys PLA(2). Overall, although AdPLA is similar to other histidine phospholipases in pH and calcium dependence, AdPLA showed different characteristics in many regards, including predicted catalytic mechanism. AdPLA may therefore represent the first member of a new group of PLA(2)s, group XVI.

Indexed as

3T3 CellsAdipocytesAdipose TissueAmidesAnimalsArachidonic AcidsChlorocebus aethiopsCOS CellsFatty Acids, UnsaturatedLysophospholipidsMiceModels, BiologicalPhosphatidylcholinesPhospholipases A2Sulfides7,7-dimethyl-5,8-eicosadienoic acidadipose-specific phospholipase A2, ratAmidesArachidonic AcidsarachidonyltrifluoromethaneFatty Acids, UnsaturatedLysophospholipidsPhosphatidylcholinesPhospholipases A2Sulfides

Identifiers

PMID18614531
PMCPMC2533091
OpenAlexW2057723954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.